Norry Elliot
Insider CIK 1798117 · ADAP Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2025-02-20 | 2025-02-20 | 1,612,032 | — | $0 | 1,612,032 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2025-02-20 | 2025-02-20 | 1,074,696 | — | $0 | 1,074,696 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2025-01-17 | 2025-01-17 | 5,584 | $0.58 | $3.2K | 7,510 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2025-01-15 | 2025-01-15 | 9,803 | $0.57 | $5.6K | 13,756 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2025-01-13 | 2025-01-15 | 8,124 | $0.59 | $4.8K | 11,516 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2025-01-13 | 2025-01-15 | 4,268 | $0.59 | $2.5K | 5,845 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2024-01-17 | 2024-01-17 | 12,967 | $0.67 | $8.7K | 19,257 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2024-01-17 | 2024-01-17 | 5,309 | $0.67 | $3.6K | 7,785 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2024-01-16 | 2024-01-17 | 2,287 | $0.79 | $1.8K | 3,363 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2024-01-15 | 2024-01-17 | 565,416 | — | $0 | 565,416 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2024-01-15 | 2024-01-17 | 2,544,432 | — | $0 | 2,544,432 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2024-01-12 | 2024-01-12 | 7,799 | $0.85 | $6.6K | 11,841 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2024-01-11 | 2024-01-12 | 4,009 | $0.84 | $3.4K | 6,104 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2023-01-17 | 2023-01-17 | 1,407,072 | — | $0 | 1,407,072 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2023-01-17 | 2023-01-17 | 314,256 | — | $0 | 314,256 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2023-01-17 | 2023-01-17 | 193,344 | — | $0 | 193,344 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2023-01-17 | 2023-01-17 | 2,159 | $1.86 | $4.0K | 3,491 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2023-01-12 | 2023-01-12 | 7,449 | $1.71 | $12.7K | 12,191 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2023-01-11 | 2023-01-12 | 3,843 | $1.75 | $6.7K | 6,270 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2023-01-04 | 2023-01-04 | 876 | $1.69 | $1.5K | 1,361 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2022-01-18 | 2022-01-18 | 2,121 | $3.19 | $6.8K | 3,529 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2022-01-12 | 2022-01-13 | 2,110,608 | — | $0 | 2,110,608 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2022-01-12 | 2022-01-13 | 471,360 | — | $0 | 471,360 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2022-01-12 | 2022-01-13 | 854 | $3.54 | $3.0K | 1,383 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2022-01-11 | 2022-01-13 | 3,770 | $3.56 | $13.4K | 6,343 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2022-01-04 | 2022-01-05 | 849 | $4.06 | $3.4K | 1,388 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2021-01-19 | 2021-01-19 | 2,111 | $5.67 | $12.0K | 3,539 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2021-01-12 | 2021-01-12 | 841 | $6.15 | $5.2K | 1,396 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2021-01-11 | 2021-01-11 | 1,086,816 | — | $0 | 1,086,816 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2021-01-11 | 2021-01-11 | 242,712 | — | $0 | 242,712 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2021-01-04 | 2021-01-05 | 845 | $5.33 | $4.5K | 1,392 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2020-01-16 | 2020-01-17 | 135,600 | — | $0 | 135,600 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2020-01-16 | 2020-01-17 | 201,600 | — | $0 | 201,600 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2020-01-14 | 2020-01-15 | 911 | $5.13 | $4.7K | 1,326 | SEC↗ |